gene expression analysis
RxPONDER Update Yields No Clear Guidance on Chemo Decisions for Younger Breast Cancer Patients
Premium
A large, randomized trial exploring the benefit of adding chemo to endocrine therapy for premenopausal women with Oncotype DX scores of 0 to 25 will likely be needed.
Rebus Biosystems Acquires IP, Assay Assets of EEL Transcriptomics
The EEL assay will be available for use on the Rebus Esper system through early access in the first half of 2022, followed by a commercial launch in June.
NanoString Projects Q4 Instrument Growth; Sees Strong Early Demand for New Spatial Imaging Platform
Premium
Company executives said that they are seeing high demand for projects involving its forthcoming CosMx spatial molecular imager.
NanoString Technologies Q3 Revenues Grow 17 Percent
The company recorded $37.2 million in total revenues, short of analysts' consensus estimate of $37.8 million.
Ulcerative Colitis Study Analyzes Gene Expression to Measure Risk of Progression to Surgery
RNA data helped researchers develop a predicted polygenic transcriptional risk score that identified UC patients at fivefold elevated risk of colectomy.
Apr 7, 2021
Qlucore Raises SEK 30M as it Looks Toward IPO
Mar 18, 2021
Mar 5, 2021
Feb 18, 2021
Feb 1, 2021